Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 2001 Jan;91(1):31–37. doi: 10.2105/ajph.91.1.31

Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness.

S D Rosenberg 1, L A Goodman 1, F C Osher 1, M S Swartz 1, S M Essock 1, M I Butterfield 1, N T Constantine 1, G L Wolford 1, M P Salyers 1
PMCID: PMC1446494  PMID: 11189820

Abstract

OBJECTIVES: This study assessed seroprevalence rates of HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) among individuals with severe mental illness. METHODS: Participants (n = 931) were patients undergoing inpatient or outpatient treatment in Connecticut, Maryland, New Hampshire, or North Carolina. RESULTS: The prevalence of HIV infection in this sample (3.1%) was approximately 8 times the estimated US population rate but lower than rates reported in previous studies of people with severe mental illness. Prevalence rates of HBV (23.4%) and HCV (19.6%) were approximately 5 and 11 times the overall estimated population rates for these infections, respectively. CONCLUSIONS: Elevated rates of HIV, HBV, and HCV were found. Of particular concern are the high rates of HCV infection, which are frequently undetected. Individuals with HCV infection commonly fail to receive appropriate treatment to limit liver damage and unknowingly may be a source of infection to others.

Full Text

The Full Text of this article is available as a PDF (95.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter M. J., Mast E. E., Moyer L. A., Margolis H. S. Hepatitis C. Infect Dis Clin North Am. 1998 Mar;12(1):13–26. doi: 10.1016/s0891-5520(05)70405-0. [DOI] [PubMed] [Google Scholar]
  2. Alter M. J., Mast E. E. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am. 1994 Sep;23(3):437–455. [PubMed] [Google Scholar]
  3. Barbaro G., Di Lorenzo G., Belloni G., Ferrari L., Paiano A., Del Poggio P., Bacca D., Fruttaldo L., Mongiò F., Francavilla R. Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial. Am J Med. 1999 Aug;107(2):112–118. doi: 10.1016/s0002-9343(99)00160-6. [DOI] [PubMed] [Google Scholar]
  4. Carey M. P., Carey K. B., Kalichman S. C. Risk for human immunodeficiency virus (HIV) infection among persons with severe mental illnesses. Clin Psychol Rev. 1997;17(3):271–291. doi: 10.1016/s0272-7358(97)00019-6. [DOI] [PubMed] [Google Scholar]
  5. Chang T. T., Lin H., Yen Y. S., Wu H. L. Hepatitis B and hepatitis C among institutionalized psychiatric patients in Taiwan. J Med Virol. 1993 Jun;40(2):170–173. doi: 10.1002/jmv.1890400216. [DOI] [PubMed] [Google Scholar]
  6. Chawarski M. C., Pakes J., Schottenfeld R. S. Assessment of HIV risk. J Addict Dis. 1998;17(4):49–59. doi: 10.1300/J069v17n04_05. [DOI] [PubMed] [Google Scholar]
  7. Di Nardo V., Petrosillo N., Ippolito G., Bonaventura M. E., Puro V., Chiaretti B., Tosoni M. Prevalence and incidence of hepatitis B virus, hepatitis C virus and human immunodeficiency virus among personnel and patients of a psychiatric hospital. Eur J Epidemiol. 1995 Apr;11(2):239–242. doi: 10.1007/BF01719496. [DOI] [PubMed] [Google Scholar]
  8. Drake R. E., Mercer-McFadden C., Mueser K. T., McHugo G. J., Bond G. R. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull. 1998;24(4):589–608. doi: 10.1093/oxfordjournals.schbul.a033351. [DOI] [PubMed] [Google Scholar]
  9. El-Serag H. B., Mason A. C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999 Mar 11;340(10):745–750. doi: 10.1056/NEJM199903113401001. [DOI] [PubMed] [Google Scholar]
  10. Goldman H. H., Gattozzi A. A., Taube C. A. Defining and counting the chronically mentally ill. Hosp Community Psychiatry. 1981 Jan;32(1):21–27. doi: 10.1176/ps.32.1.21. [DOI] [PubMed] [Google Scholar]
  11. Hoofnagle J. H., Schafer D. F. Serologic markers of hepatitis B virus infection. Semin Liver Dis. 1986 Feb;6(1):1–10. doi: 10.1055/s-2008-1040787. [DOI] [PubMed] [Google Scholar]
  12. Kalichman S. C., Kelly J. A., Johnson J. R., Bulto M. Factors associated with risk for HIV infection among chronic mentally ill adults. Am J Psychiatry. 1994 Feb;151(2):221–227. doi: 10.1176/ajp.151.2.221. [DOI] [PubMed] [Google Scholar]
  13. Karon J. M., Rosenberg P. S., McQuillan G., Khare M., Gwinn M., Petersen L. R. Prevalence of HIV infection in the United States, 1984 to 1992. JAMA. 1996 Jul 10;276(2):126–131. [PubMed] [Google Scholar]
  14. Kelly J. A. HIV risk reduction interventions for persons with severe mental illness. Clin Psychol Rev. 1997;17(3):293–309. doi: 10.1016/s0272-7358(97)00020-2. [DOI] [PubMed] [Google Scholar]
  15. Kelly J. A., McAuliffe T. L., Sikkema K. J., Murphy D. A., Somlai A. M., Mulry G., Miller J. G., Stevenson L. Y., Fernandez M. I. Reduction in risk behavior among adults with severe mental illness who learned to advocate for HIV prevention. Psychiatr Serv. 1997 Oct;48(10):1283–1288. doi: 10.1176/ps.48.10.1283. [DOI] [PubMed] [Google Scholar]
  16. McKinnon K., Cournos F. HIV infection linked to substance use among hospitalized patients with severe mental illness. Psychiatr Serv. 1998 Oct;49(10):1269–1269. doi: 10.1176/ps.49.10.1269. [DOI] [PubMed] [Google Scholar]
  17. McQuillan G. M., Khare M., Karon J. M., Schable C. A., Vlahov D. Update on the seroepidemiology of human immunodeficiency virus in the United States household population: NHANES III, 1988-1994. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Apr 1;14(4):355–360. doi: 10.1097/00042560-199704010-00008. [DOI] [PubMed] [Google Scholar]
  18. Regier D. A., Farmer M. E., Rae D. S., Locke B. Z., Keith S. J., Judd L. L., Goodwin F. K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990 Nov 21;264(19):2511–2518. [PubMed] [Google Scholar]
  19. Rosenberg S. D., Drake R. E., Wolford G. L., Mueser K. T., Oxman T. E., Vidaver R. M., Carrieri K. L., Luckoor R. Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness. Am J Psychiatry. 1998 Feb;155(2):232–238. doi: 10.1176/ajp.155.2.232. [DOI] [PubMed] [Google Scholar]
  20. Schalm S. W., Brouwer J. T., Chemello L., Alberti A., Bellobuono A., Ideo G., Schwartz R., Weiland O. Interferon-ribavirin combination therapy for chronic hepatitis C. Dig Dis Sci. 1996 Dec;41(12 Suppl):131S–134S. doi: 10.1007/BF02087889. [DOI] [PubMed] [Google Scholar]
  21. Schinnar A. P., Rothbard A. B., Kanter R., Jung Y. S. An empirical literature review of definitions of severe and persistent mental illness. Am J Psychiatry. 1990 Dec;147(12):1602–1608. doi: 10.1176/ajp.147.12.1602. [DOI] [PubMed] [Google Scholar]
  22. Schvarcz R., Yun Z. B., Sönnerborg A., Weiland O. Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone. J Med Virol. 1995 May;46(1):43–47. doi: 10.1002/jmv.1890460110. [DOI] [PubMed] [Google Scholar]
  23. Susser E., Valencia E., Berkman A., Sohler N., Conover S., Torres J., Betne P., Felix A., Miller S. Human immunodeficiency virus sexual risk reduction in homeless men with mental illness. Arch Gen Psychiatry. 1998 Mar;55(3):266–272. doi: 10.1001/archpsyc.55.3.266. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES